Colorectal cancer: cetuximab, KRAS, BRAF, PIK3CA mutations and beyond
dc.contributor.author | Katsios, C. | en |
dc.contributor.author | Ziogas, D. E. | en |
dc.contributor.author | Roukos, D. H. | en |
dc.date.accessioned | 2015-11-24T19:29:47Z | |
dc.date.available | 2015-11-24T19:29:47Z | |
dc.identifier.issn | 1747-4132 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/22996 | |
dc.rights | Default Licence | - |
dc.subject | Antibodies, Monoclonal/*therapeutic use | en |
dc.subject | Antineoplastic Agents/*therapeutic use | en |
dc.subject | Colorectal Neoplasms/*drug therapy/genetics/mortality/pathology | en |
dc.subject | Genetic Testing | en |
dc.subject | Genotype | en |
dc.subject | Humans | en |
dc.subject | Molecular Targeted Therapy | en |
dc.subject | *Mutation | en |
dc.subject | Patient Selection | en |
dc.subject | Phenotype | en |
dc.subject | Phosphatidylinositol 3-Kinases/*genetics | en |
dc.subject | Proto-Oncogene Proteins/*genetics | en |
dc.subject | Proto-Oncogene Proteins B-raf/*genetics | en |
dc.subject | Treatment Outcome | en |
dc.subject | ras Proteins/*genetics | en |
dc.title | Colorectal cancer: cetuximab, KRAS, BRAF, PIK3CA mutations and beyond | en |
heal.access | campus | - |
heal.fullTextAvailability | TRUE | - |
heal.identifier.primary | 10.1586/egh.10.62 | - |
heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/20932136 | - |
heal.identifier.secondary | http://www.expert-reviews.com/doi/pdfplus/10.1586/egh.10.62 | - |
heal.journalName | Expert Rev Gastroenterol Hepatol | en |
heal.journalType | peer-reviewed | - |
heal.language | en | - |
heal.publicationDate | 2010 | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
heal.type | journalArticle | - |
heal.type.el | Άρθρο Περιοδικού | el |
heal.type.en | Journal article | en |
Αρχεία
Φάκελος/Πακέτο αδειών
1 - 1 of 1
Φόρτωση...
- Ονομα:
- license.txt
- Μέγεθος:
- 1.74 KB
- Μορφότυπο:
- Item-specific license agreed upon to submission
- Περιγραφή: